Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model
- 29 November 2001
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 54 (2) , 69-78
- https://doi.org/10.1016/s0166-3542(01)00216-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- ANIMAL MODELS OF HEPATITIS B VIRUS INFECTIONClinics in Liver Disease, 1999
- Evolving therapies for the treatment of viral hepatitisEmerging Drugs, 1999
- Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infectionHepatology, 1998
- Lamivudine Therapy of WHV-Infected WoodchucksVirology, 1998
- Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse modelAntimicrobial Agents and Chemotherapy, 1992
- Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replicationAntiviral Research, 1992
- Long-term follow-up of anti-HBe-positive chronic active hepatitis BHepatology, 1988
- THE MOLECULAR BIOLOGY OF THE HEPATITIS B VIRUSESAnnual Review of Biochemistry, 1987
- Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice.Proceedings of the National Academy of Sciences, 1987
- A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks.Proceedings of the National Academy of Sciences, 1978